MARY PAQUET: Open Payments
NPI 1235791369 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 27 payments from 11 companies in 2025. Trend: 2023 $614 · 2024 $1,285 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $229 |
| Axsome Therapeutics, Inc. | 5 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Alkermes, Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: Wegovy, Auvelity, CAPLYTA, MOUNJARO, INGREZZA, LYBALVI, SPRAVATO, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
